Clinical Trials on Lymphatic in Switzerland

Total 245 results

Nicole Lindenblatt
University Hospital, Zürich; Swiss Federal Institute of Technology; Zurich University... and other collaborators

Completed

Proof-of-concept Study of LymphMonitor 1.0 to Assess the Lymphatic Vessel Function

Lymphedema | Secondary Lymphedema

Switzerland
University Hospital Inselspital, Berne

Completed

Outcome After Conservative and Surgical Treatment of Splenic Injuries After Blunt Abdominal Trauma.

Abdominal Injuries | Splenic Rupture

Switzerland
Insel Gruppe AG, University Hospital Bern
Mundipharma Medical Company

Suspended

Brentuximab Vedotin and BeEAM High-dose Chemotherapy in Lymphomas (BAL)

Lymphoma

Switzerland
University of Lausanne Hospitals

Completed

A Study for Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Radical Lymph Node Dissection

Lymphoedema | Lymph Node Dissection | Lymphocoele

Switzerland
Oncology Institute of Southern Switzerland
Ente Ospedaliero Cantonale, Bellinzona; Istituto Cantonale di Patologia

Recruiting

Tumor Molecular Profiling in Early Phase Clinical Trials

Lymphoma | Advanced Solid Tumor

Switzerland
University Hospital, Basel, Switzerland
Sana Kliniken Düsseldorf GmbH

Recruiting

An Integrated Algorithm for Surgical Intervention in Chronic Lymphedema After Breast Cancer Treatment: The Basel Lymphedema Protocol

Breast Cancer | Lymphedema

Switzerland
University of Zurich

Completed

Characterization of Laryngeal Contact Granulomas: Retrospective Analysis of Symptoms, Promotive Factors and Therapy

Laryngeal Contact Granuloma

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia

Leukemia

Switzerland
Luzerner Kantonsspital

Recruiting

Role of Intrapulmonary Lymph Nodes in Patients With NSCLC and Visceral Pleural Invasion

Lung Cancer | Lymph Node Metastasis

Switzerland
University of Geneva, Switzerland

Terminated

Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion Syndrome

22q11.2 Deletion Syndrome

Switzerland
University of Geneva, Switzerland

Completed

Effects of Methylphenidate on Brain and Cognition in 22q11 Deletion Syndrome

22q11.2 Deletion Syndrome

Switzerland
Lymphatica Medtech SA

Terminated

LymphoPilot Test for Limb Lymphedema

Lymphedema of Upper Limb | Lymphedema, Secondary | Lymphedema, Lower Limb | Lymphedema of Leg | Lymphedema Arm

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy

Leukemia

Switzerland
Insel Gruppe AG, University Hospital Bern

Enrolling by invitation

Inflammatory Cardiomyopathy Bern Registry (FlamBer)

Myocarditis | Pericarditis | Cardiac Sarcoidosis

Switzerland
Stephan Eliez

Recruiting

Using Transcranial Alternating Current Stimulation to Improve Executive Function in 22q11.2 Deletion Syndrome

tACS | 22Q11 Deletion Syndrome

Switzerland
Daniel Franzen
B. Braun Melsungen AG

Completed

Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy

Lung Cancer | Sarcoidosis | Interstitial Pneumonia

Switzerland
University Hospital Inselspital, Berne

Active, not recruiting

CD34+ Selected ASCT for Aggressive Lymphomas (SAAL)

Malignant Non-Hodgkin Lymphomas

Switzerland
University Hospital Inselspital, Berne

Completed

Pedometer Activity Monitoring After ASCT (PAMAL)

Lymphoma | Myeloma | Autologous Stem Cell Transplantation | High-dose Chemotherapy

Switzerland
International Extranodal Lymphoma Study Group (IELSG)

Completed

Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma

Lymphoma, B Cell

Switzerland
Insel Gruppe AG, University Hospital Bern

Not yet recruiting

PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab) (PRONTO)

Lymphoma | Leukemia | Myeloma

Switzerland
International Extranodal Lymphoma Study Group (IELSG)

Completed

Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma

Lymphoma, B Cell

Switzerland
International Extranodal Lymphoma Study Group (IELSG)

Completed

VELCADE in MALT Lymphoma Pretreated With Prior Systemic Therapy

Lymphoma, Mucosa-Associated Lymphoid Tissue

Switzerland
International Extranodal Lymphoma Study Group (IELSG)

Terminated

VELCADE in MALT Lymphoma Pretreated With More Than One Prior Systemic Therapy

Lymphoma, Mucosa-Associated Lymphoid Tissue

Switzerland
International Extranodal Lymphoma Study Group (IELSG)

Completed

Integrated Molecular and Clinical Profiling to Optimize Outcome Prediction in Splenic Marginal Zone Lymphoma

Splenic Marginal Zone Lymphoma

Switzerland
Oncology Institute of Southern Switzerland

Recruiting

Liquid Biopsy in Mature B-cell Tumors

Mature B-Cell Neoplasm

Switzerland
Kantonsspital Graubuenden
Swiss Group for Clinical Cancer Research

Completed

SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience

Prostate Cancer | Prostate Cancer Recurrent | Lymph Node Metastases

Switzerland
Hospices Civils de Lyon

Unknown

CHUSPAN SCS BP Treatment of Churg-Strauss Syndrome Without Poor-Prognosis Factors

Churg-Strauss Syndrome

Switzerland
MMI Spa

Recruiting

PRIMO Post-Market Clinical Follow Up Study (PRIMO)

Open Surgery | Blood Vessels, Lymphatic Ducts and Nerves | Free Flaps

Spain, Switzerland, Italy, Belgium, Austria, Germany
University of Zurich

Completed

Determination of Blood Tumor Cells

Leukemia, Lymphocytic, Chronic, B-Cell | Abnormalities Cell Epithelial

Switzerland
Ethical Oncology Science

Completed

Phase I Study of the Proteosome Inhibitor CEP 18770 in Patients With Solid Tumours or Non-Hodgkin's Lymphomas

Lymphoma, Non-Hodgkin | Solid Tumors

Switzerland, Italy
University Hospital, Geneva

Recruiting

Liquid Biopsy to Enable Diagnostics and Monitoring for Immune-mediated Lymphoproliferative Disorders (LIMPID)

Lymphoproliferative Disorders | Lymphoproliferative Disorder Following Transplantation

Switzerland
European Organisation for Research and Treatment...
Mallinckrodt

Withdrawn

Study of Photopheresis in the Treatment of Erythrodermic MF and SS (PROMPT)

Lymphoma, T-Cell, Cutaneous | Mycosis Fungoides/Sezary Syndrome

Switzerland
Cristiana Sessa

Completed

Study of Inotuzumab Ozogamicin + Temsirolimus in Patients With Relapsed or Refractory CD22+ B-cell NHLymphoma (IOSI-LND-001)

B-cell Lymphoma Refractory

Switzerland
John O. Prior

Recruiting

[68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation

Cardiac Sarcoidosis | Acute Cellular Graft Rejection | Myocarditis Due to Drug

Switzerland
University of Zurich

Unknown

Lymphoma in the Orbit

Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma

Switzerland
University Hospital, Geneva

Active, not recruiting

A Study on Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive B-Lymphoma (FRILLY)

Aggressive B-Cell Non-Hodgkin Lymphoma

Switzerland
University Hospital Inselspital, Berne
Swiss National Science Foundation

Completed

USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases

Prostate Cancer | Bladder Cancer

Switzerland
University of Zurich
Goethe University

Completed

Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) in Children (XCGDinChildren)

Chronic Granulomatous Disease

Switzerland
National Cancer Institute (NCI)

Completed

Raltitrexed in Treating Children With Refractory Acute Leukemia

Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid Leukemia

Switzerland
Malcolm Kohler

Completed

Obstructive Sleep Apnoea in Sarcoidosis (OSASA)

Fatigue | Obstructive Sleep Apnea | Sarcoidosis | Sleepiness

Switzerland
Insel Gruppe AG, University Hospital Bern

Recruiting

Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)? (FatIgG)

Multiple Sclerosis | Fatigue | Hypogammaglobulinemia

Switzerland
Swiss Pediatric Oncology Group
ALL SCTped Forum

Recruiting

ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)

Acute Lymphoblastic Leukemia

Switzerland
Merck KGaA, Darmstadt, Germany

Completed

EMD 521873 in Advanced Solid Tumors, MTD Finding

Non-Hodgkin Lymphoma

Germany, Switzerland
University Hospital, Basel, Switzerland

Not yet recruiting

EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases (ESPECT)

EBV Lymphoma | Post-transplant Lymphoproliferative Disease (PTLD)

Switzerland
University Hospital Inselspital, Berne
Hanusk Krankenhaus Wien

Completed

A Trial Comparing the Two High-dose Chemotherapies BeEAM and BEAM Given Before Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients (BEB-trial) (BEB)

Lymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-Cell

Switzerland, Austria
Swiss Group for Clinical Cancer Research

Completed

Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients

Follicular Lymphoma

Switzerland
European Organisation for Research and Treatment...
Hoffmann-La Roche

Terminated

PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL) (PARCT)

Lymphoma, T-Cell, Cutaneous | Mycosis Fungoides/Sezary Syndrome

Spain, Switzerland
Oncology Institute of Southern Switzerland
Azienda Ospedaliero Universitaria Maggiore della Carita; Arcispedale Santa... and other collaborators

Active, not recruiting

Personalized Risk Stratification Model of Follicular Lymphoma Patients

Follicular Lymphoma

Italy, Switzerland
Swiss Group for Clinical Cancer Research

Completed

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Lymphoma

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma

Lymphoma

Switzerland

Clinical Trials on Lymphatic in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations